Resilience To Get $164M for Site Expansion
Resilience, a recently launched manufacturing and technology company for biologics and advanced therapies that recently acquired UF startup and UF Innovate | Sid Martin Biotech graduate Ology Bioservices, will receive a $164-million investment from the Canadian government to modernize and expand the biomanufacturing site of its Mississauga, Ontario, Canada-based subsidiary, Resilience Biotechnologies Inc. (RBI).
This project will help increase manufacturing capacity for vaccines and therapeutics, including novel technologies such as mRNA that are now being used to fight COVID-19.
Read more about Resilience To Get $164M for Site Expansion.